Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

The American College of Cardiology (ACC) annual meeting ACC.22 is the premier source for the latest cardiac science. #ACC22 Here are links to all the late breaking studies, trials and late-breaker science at the annual meeting conference. #ACC2022 #ACC

Links to the ACC.22 late-breaking clinical trials

Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C. 

April 13, 2022
Nurses caring for a COVID-19 patient in the COVID unit at Banner University Medical Center in Phoenix.

An updated look at what cardiologists know about heart damage among COVID-19 patients

An international analysis published in Circulation and a new scientific statement from the American Heart Association both explore the latest data on heart complications associated with COVID-19. 

April 13, 2022
Researchers are using an intra-atrial shunt to lower pressures between the upper chambers of the heart to relieve symptoms in HFpEF heart failure patients. The novel Noya device uses an RF ablation to cut a hole into the septum and then enlarge it using a stent that can then be removed from the body after the procedure. 

Researchers share first human data on new interventional shunt procedure for HFpEF

The first-in-man study, completed by a team of cardiologists in China, included 10 patients presenting with HFpEF. 

April 7, 2022

European Society of Cardiology publishes new genetic testing guidelines for heart conditions

The new international consensus document gives detailed recommendations on when to offer genetic testing for patients and their family members. 

April 7, 2022
Steven E. Nissen, MD, discusses his late-breaking clinical trial with panelist Vera Bittner, MD.

Cholesterol medications, flu shots and heart failure: Day 2 at ACC.22

Day 2 of ACC.22 was jam-packed with late-breaking clinical trials. Read our quick rundown of what researchers shared with the public for the very first time. 

April 4, 2022
Cardiologist heart

Cardiology groups debut new heart failure guidelines ahead of ACC.22

The new recommendations went live just ahead of ACC.22. They can be read in full in the Journal of the American College of Cardiology, Circulation or Journal of Cardiac Failure.

April 1, 2022
Congress dome capitol Washington

Congress investigating FDA over heart device recall, says agency ‘failed to protect consumers’

“I am concerned by the FDA’s slow action, over multiple administrations, to protect patients from this product despite early warning signs,” one U.S. representative said in an open letter. 

March 31, 2022

Researchers to develop spirituality screening tool for heart failure patients

A new literature review finds suggested links between higher spirituality and a higher quality of life for heart failure patients.

March 28, 2022

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup